Considerations in assessing effectiveness and costs of diabetes care: Lessons from DARTS

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue SUPPL. 3, 2002, Pages

  Morris, Andrew D ^a,b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Blindness; DARTS; Diabetes audit; Hypertension; Saint Vincent Declaration

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ACUTE HEART INFARCTION; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE PLANNING; HEART INFARCTION; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT MONITORING; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SECONDARY PREVENTION; SOCIOECONOMICS; STANDARD; TREATMENT OUTCOME; UNITED KINGDOM;

COSTS AND COST ANALYSIS; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; QUALITY ASSURANCE, HEALTH CARE; SCOTLAND;

EID: 0036711088     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.295     Document Type: Article

References (8)

1. Morris AD, Boyle DIR, MacAlpine R, et al. for the DARTS/MEMO Collaboration. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. BMJ 1997; 315: 524-528.
2. Evans JMM, Newton RW, Ruta DA, MacDonald TM, Morris AD. Socio-economic status, obesity and prevalence of type 1 and type 2 diabetes mellitus. Diabet Med 2000; 17: 478-480.
3. Donnan PT, Boyle IR, Broomhall J, et al. Prognosis following first acute myocardial infarction in type 2 diabetes: a comparative population study. Diabet Med 2002; 19: 448-455.
4. MacDonald TM, Butler R, Newton RW, Morris AD, for the DARTS/MEMO Collaboration. Which drugs benefit diabetic patients for secondary prevention of myocardial infarction? Diabet Med 1998; 15: 282-289.
5. Liebl A, Neiss A, Spannheimer A, Reitberger U, Wagner T, Gortz A. Costs of type 2 diabetes in Germany. Results of the CODE-2 study. Dtsch Med Wochenschr 2001; 126: 585-589.
6. Diabetes Care and Research in Europe: the Saint Vincent Declaration. Diabet Med 1990; 7: 360.
7. United Kingdom Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
8. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med 2002; 19: 279-284.